ClinicalTrials.Veeva

Menu

Measurement Properties in People with Hemophilia (HEMOPRO)

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Enrolling

Conditions

Musculoskeletal Complication
Hemophilia B
Measurement Error
Hemophilia a

Treatments

Other: Measurement Properties (Reliability and Validity) of a Set of Assessments evaluating Physical Function in adult Participants with Hemophilia

Study type

Interventional

Funder types

Other

Identifiers

NCT06565481
2024-01354

Details and patient eligibility

About

The aim of this project is to determine the measurement properties (namely reliability and validity) of a set of clinical assessments, measuring different aspects of physical function.

Full description

The medical treatment of hemophilia has advanced greatly in recent years. There are now medications that reduce the physical symptoms of hemophilia. Nevertheless, those affected by hemophilia suffer from restricted mobility, reduced strength, reduced balance and pain as a result of the repeated bleeding. In order to make well-founded decisions regarding possible supportive therapeutic or medical measures, it is important to be able to estimate the extent of such limitations and whether these will change or remain stable.

The study is needed to validate the measurement properties of measurement instruments used to measure the effects of physical training interventions in participants with hemophilia. Clinical questions can only be solved if measuring instruments with sufficient measuring properties are used. These measurement properties must be evaluated in a relevant population. Otherwise, health professionals cannot assess whether measures or treatment are not effective or whether measured changes are not large enough to detect an actual change. Therefore, research is required to ensure that adequately studied measurement instruments are available for clinical assessment of those affected by adult participants with hemophilia.

Some of the tests (such as the Unipedal Stance Test or Four Square Step Test) have already been studied in children with hemophilia or in participants with other diseases. Since hemophilia is a disease with specific effects, the measuring instruments must also be researched in this participant group. There is still a research gap that the investigators would like to close with this study. For the study, the investigators selected tests that are already being used on adult participants with hemophilia and have had good experiences in practice. The tests are safe and can be carried out with little strain.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed Hemophilia Types A or B
  • Adult people ≥ 18 years
  • Patients on prophylactic factor or non-factor replacement treatment, or on demand factor replacement treatment.
  • Able to walk for 20 meters independently, with or without walking aid
  • Signed informed consent to participate in the study

Exclusion criteria

  • Severe health conditions like severe cardiovascular, pulmonary, neurological or musculoskeletal diseases.
  • Unable to perform the assessments due to disability or language problems.

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

Single Test-Re Test Arm
Other group
Description:
This study, including two time points, is performed to determine validity and reliability of performance based assessments using a one-arm sample. A test retest design is used to determine reliability and a cross-sectional design to determine validity. For each participant, the measures will be performed on two time points with a minimal recovery break of 2 days in one single centre in the Canton of Zurich (University Hospital Zurich).
Treatment:
Other: Measurement Properties (Reliability and Validity) of a Set of Assessments evaluating Physical Function in adult Participants with Hemophilia

Trial contacts and locations

1

Loading...

Central trial contact

Andrea Baerlocher, MSc; Ruud H Knols, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems